Lipoprotein-associated phospholipase A2 antibody compositions and methods of use
US9000132B2 · kind B2 · utility
3Cited by
56References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2013 |
| Grant date | Apr 7, 2015 |
| Priority date | — |
| Expiry date | Jul 31, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/92
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides isolated anti-Lp-PLA2 antibodies that bind to Lp-PLA2. The invention also encompasses compositions comprising an anti-Lp-PLA2 antibody. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Lp-PLA2 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Lp-PLA2 antibodies. The invention encompasses a method of producing the anti-Lp-PLA2 antibodies. Other aspects of the invention are a method of detecting an Lp-PLA2 in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.